Skip to headlines

BUSINESS

HHS plans new FDA deputy commissioner roles for technology and drugs, sources say

CNBC BusinessTuesday, August 25, 2026 at 5:00 PM

RedScroll Brief

HHS plans to name two deputy commissioners for technology and drugs, said two sources familiar with the matter.

RedScroll Signal

Impact
High
Category
Business
Market relevance
High
Why it matters
Corporate and market moves reprice risk and reveal where power and cash are concentrating. HHS plans to name two deputy commissioners for technology and drugs, said two sources familiar with the matter. Investors will watch earnings, rates, and competitive positioning connected to Business.
Read original source → CNBC BUSINESSEdition 2026-08-25

Desk copy

RedScroll Briefing

Extractive editorial brief — not a reprint of the original

What happened

HHS plans to name two deputy commissioners for technology and drugs, said two sources familiar with the matter.

Why it matters

Corporate and market moves reprice risk and reveal where power and cash are concentrating.

Background

CNBC Business reported on this under business. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.

Timeline

  1. CNBC Business published: HHS plans new FDA deputy commissioner roles for technology and drugs, sources say

  2. Story is in today’s RedScroll edition. Follow the original source for updates.

Economic impact

Investors will watch earnings, rates, and competitive positioning connected to Business.

More on

Related stories

Source

CNBC Business

Original reporting by CNBC Business. RedScroll provides an extractive briefing only.